Alzheimer Dementia (AD) Recruiting Phase 3 Trials for Brexpiprazole (DB09128)

Also known as: Alzheimer's Dementia / Alzheimer Dementia

IndicationStatusPhase
DBCOND0078271 (Alzheimer Dementia (AD))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03548584A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's TypeTreatment